Personalized medicine (beyond PET biomarkers)
Personalized medicine Pharmacogenetics
Nova Science Publisher's, Inc.
2016
EISBN 9781634853330
Dedication; Contents; Words of Wisdom; About this Book; Preface; Acknowledgments; About the Author; Abbreviations; Fundamental of Evidence-Based; Personalized Theranostics; Abstract; Introduction; Pharmacogenomics; Personalized Treatment; Degrees of Relationship; Future Prospects of EBPT; Acknowledgment; References; PET Biomarkers in Evidence-Based Personalized Theranostics (Recent Update); Abstract; Introduction; References; Human Genomics in Evidence-Based Personalized Theranostics (Recent Update); Abstract; Introduction; References.
Evidence-Based Personalized Theranostics (Recent Update-I)Abstract; Introduction; References; Evidence-Based Personalized Theranostics (Recent Update-II); Abstract; Introduction; EBPT Biotechnology; Pharmacogenomics; Disease-Specific Biomarkers; EBPT of Cancer; EBPT of Neurodegenerative Disorders; EBPT of Drug Addiction; EBPT of Diabetes; EBPT of Cardiovascular Diseases; EBPT of Miscellanous Diseases; References; Nanotechnology and Pharmacogenomics; in Evidence-Based Personalized Theranostics (Recent Update); Abstract; Introduction; References.
Nanotechnology in Evidence-Based Personalized Theranostics (Recent Update)Abstract; Introduction; Conclusion; References; Biomarkers in Personalized Theranostics; of Neurodegenerative Diseases; Biomarkers in Personalized Theranostics; of Fetal Alcohol Syndrome; Abstract; Introduction; Microcephaly in Developing Brain; Conclusion; References; Biomarkers in Personalized Theranostics; of Parkinson's Disease; Abstract; Introduction; Conclusion; References; Biomarkers in Personalized Theranostics; of Alzheimer's Disease (Recent Update); Abstract; Introduction; In-Vitro Molecular Biomarkers in AD.
Omic Biomarkers in MSCytokines as Biomarkers in MS; Micro-RNAs as Biomarkers in MS; MRI Biomarkers in MS; In-Vivo Imaging Biomarkers in MS; Personalized Theranostics of MS; Conclusion; References; Index.
Omics Biomarkers in ADGenetic Biomarkers in AD; Technical and Clinical Issues in Biomarker Estimations; In-Vivo Molecular Biomarkers in AD; Miscellaneous Biomarkers in AD; Comparative Analyses and Pharmacodynamics of AD Biomarkers; Conclusion; References; Biomarkers in Personalized Theranostics; of Vascular Dementia; Abstract; Introduction; Conclusion; References; Biomarkers in Personalized Theranostics; of Amytropic Lateral Sclerosis; Abstract; Introduction; References; Biomarkers in Personalized Theranostics of Multiple Sclerosis (Recent Update); Abstract; Introduction.
Evidence-Based Personalized Theranostics (Recent Update-I)Abstract; Introduction; References; Evidence-Based Personalized Theranostics (Recent Update-II); Abstract; Introduction; EBPT Biotechnology; Pharmacogenomics; Disease-Specific Biomarkers; EBPT of Cancer; EBPT of Neurodegenerative Disorders; EBPT of Drug Addiction; EBPT of Diabetes; EBPT of Cardiovascular Diseases; EBPT of Miscellanous Diseases; References; Nanotechnology and Pharmacogenomics; in Evidence-Based Personalized Theranostics (Recent Update); Abstract; Introduction; References.
Nanotechnology in Evidence-Based Personalized Theranostics (Recent Update)Abstract; Introduction; Conclusion; References; Biomarkers in Personalized Theranostics; of Neurodegenerative Diseases; Biomarkers in Personalized Theranostics; of Fetal Alcohol Syndrome; Abstract; Introduction; Microcephaly in Developing Brain; Conclusion; References; Biomarkers in Personalized Theranostics; of Parkinson's Disease; Abstract; Introduction; Conclusion; References; Biomarkers in Personalized Theranostics; of Alzheimer's Disease (Recent Update); Abstract; Introduction; In-Vitro Molecular Biomarkers in AD.
Omic Biomarkers in MSCytokines as Biomarkers in MS; Micro-RNAs as Biomarkers in MS; MRI Biomarkers in MS; In-Vivo Imaging Biomarkers in MS; Personalized Theranostics of MS; Conclusion; References; Index.
Omics Biomarkers in ADGenetic Biomarkers in AD; Technical and Clinical Issues in Biomarker Estimations; In-Vivo Molecular Biomarkers in AD; Miscellaneous Biomarkers in AD; Comparative Analyses and Pharmacodynamics of AD Biomarkers; Conclusion; References; Biomarkers in Personalized Theranostics; of Vascular Dementia; Abstract; Introduction; Conclusion; References; Biomarkers in Personalized Theranostics; of Amytropic Lateral Sclerosis; Abstract; Introduction; References; Biomarkers in Personalized Theranostics of Multiple Sclerosis (Recent Update); Abstract; Introduction.
